Paroxysmal Atrial Tachycardia Market herapeutic Survey Reviews Report 2019, Growth at a CAGR of 4.5% till 2023
The market drivers for global paroxysmal atrial tachycardia market are rise in demand due to the growing geriatric population, increasing screening, greater emphasis on restorative procedures, rising safety and success of paroxysmal atrial tachycardia treatment, and others.
Market
Key Players
Some of the key players profiled in the report are Abbott Laboratories, Reliant
Pharmaceuticals, BIOTRONIK SE & Co. KG, Boston Scientific Corporation,
GlaxoSmithKline plc, GE Healthcare, Glenmark Pharmaceuticals, Koninklijke
Philips N.V., ANI Pharmaceuticals, Inc., Medtronic, Inc., Microport Scientific
Corporation, St. Jude Medical, Inc., and Siemens AG and others.
Avail a Free Sample Here: https://www.marketresearchfuture.com/sample_request/4910
The global paroxysmal
atrial tachycardia market is expected to reach USD 10.7 billion by 2023, and
the market is projected to grow at a CAGR of ~ 6.5 % during the forecast period
2017-2023.
Market Overview
Paroxysmal atrial tachycardia is a type of atrial arrhythmia
and is also known as paroxysmal supraventricular tachycardia (PSVT). PAT
increases heart rate from 60 to 100 beats per minute (bpm) to between 130 and
230 bpm with infants demonstrating substantial heart rate greater than 220 bpm.
Symptoms
of PAT may include palpitations, lightheaded, sweating, shortness of breath,
chest pain and others. PAT is not a life-threatening situation but in rare
cases, PAT may cause unconsciousness, congestive heart failure, cardiomyopathy
and cardiac arrest. Having other heart issues such heart attacks or valve
disease increase risk for PAT.
Market
Segmentation
The global paroxysmal atrial tachycardia market has
been segmented on the basis of types, condition, diagnosis, drugs, surgery and
end user.
Based
on the types, the market has been segmented as AV
nodal re-entrant tachycardia (AVNRT), AV reciprocating tachycardia (AVRT), and paroxysmal
atrial tachycardia.
Based
on the diagnosis, the market has been segmented as
electrocardiogram (ECG), echocardiogram, blood tests, and electrophysiology
study (EPS) and others.
Based
on the treatment, the market has been segmented as calcium
channel blockers, digoxin, beta-blockers, anti-arrhythmic medications, surgical
ablation and others.
Based
on the end user, the market has been segmented as
hospitals and clinics, research and academics and others.
Regional
Analysis
The Americas accounts for a significant market share
owing to high expenditure on the health care especially of the U.S. and Canada.
Additionally, the greater number of cardiac procedures due to greater
healthcare penetration in the U.S. and Canada drives the market. The high concentration
of the major hospitals in the developed countries of this region coupled with
good reimbursement rates is adding fuel to the market growth.
Brows
Complete Premium Research at https://www.marketresearchfuture.com/reports/paroxysmal-atrial-tachycardia-market-4910
Europe is the second largest market in the world due
to growing pharmaceutical industry and healthcare penetration. The European market
growth is led by countries such as Germany and France. Germany is expected to
be the fastest growing market over the assessment period due to its large
pharmaceutical and microsurgery devices industry.
Asia Pacific region is expected to grow rapidly; China and India are
likely to lead this market due to the fast growing healthcare sector and large
unmet needs over the forecast period. South East Asian countries such as China,
India, and Malaysia are projected to contribute highly to the market growth.
The growing penetration of healthcare industry in the Asia Pacific region is
expected to drive the future paroxysmal atrial tachycardia market in the
region. However the low expenditure on cardiac and eye care coupled with the
lack of insurance penetration in the developing regions is a dent on the
market.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the
Middle East & African market. Other Middle East nations to watch out for
are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a
poor growth owing to poor economic and political conditions, and poor
healthcare development. Other regions are expected to be laggards due to poor
social development and tribal identities such as sub Saharan Africa. The focus
of the governments of poor countries on fulfilling basic healthcare relegates
the paroxysmal atrial tachycardia market to the background which hampers the
development of the market.
Ask for
an Amazing Discount at: https://www.marketresearchfuture.com/check-discount/4910
At Market Research Future (MRFR), we enable
our customers to unravel the complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
In order to stay updated with technology
and work process of the industry, MRFR often plans & conducts meet with the
industry experts and industrial visits for its research analyst members.
Contact:
Market
Research Future
+1 646
845 9312
Comments
Post a Comment